Bausch + Lomb Completes Refinancing of Outstanding Term B Loans

Published on January 7, 2026
VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced that it has closed a previously announced credit agreement refinancing, entering into a fourth amendment to its credit agreement providing for a $2.8 billion ($2,802,125,000) tranche of new term B loans (replacement term loans), the proceeds of which were used to refinance all of its outstanding term B loans due in 2031 (third amendment term loans) and 2028 (first incremental term loans). The amortization rate for the replacement term loans is 1.00 percent per annum and the first installment shall be payable on June 30, 2026, the company said.
Continue reading on website
Other news

OU Health Acquires Dean McGee Eye Institute

January 7, 2026
NORMAN, Okla.—OU Health, Oklahoma’s flagship academic health system, announced it has acquired the Dean McGee Eye Institute (DMEI), a nationally recognized freestanding eye institute. The acquisition, finalized on January 1, 2026, will create the OU Health Dean McGee Eye Institute, strengthen a long-standing relationship, advance DMEI’s role in the academic health mission and honor its legacy in e

New England College of Optometry Announces 2025 Distinguished Alumni

January 7, 2026
BOSTON—New England College of Optometry (NECO) has announced its 2025 Distinguished Alumni, recognizing two exceptional graduates whose careers exemplify professional excellence, compassionate patient care, and enduring contributions to the field of optometry and their communities, the school said. This year’s honorees are Maureen Hanley, OD, class of 1981, who is being recognized posthumously, an